Loading ad...

Mechanisms of Hypersensitivity Reactions

Type IV hypersensitivity: Delayed-type cell-mediated reactions

Type IV hypersensitivity is a delayed-type reaction driven by T-cell activation, leading to inflammation and tissue damage.

6/6/20256 min read61 views
loved it
normalintermediateMicrobiology
Type IV Hypersensitivity: Causes, Mechanism & Treatment

Mechanisms of Hypersensitivity Reactions

Type IV Hypersensitivity: Delayed-Type Cell-Mediated Reactions

Type IV hypersensitivity is a cell-mediated immune response that occurs over 24 to 72 hours after exposure to an antigen. Unlike other hypersensitivity types, it does not involve antibodies but is driven by T-cell activation.

Mechanism

Upon exposure to a specific antigen, sensitized CD4+ T cells release cytokines, leading to macrophage activation and inflammation. This reaction can result in tissue damage.

Clinical Manifestations

  • Contact dermatitis
  • Tuberculin skin test reaction
  • Granulomatous inflammation

Examples and Diagnosis

Type IV hypersensitivity can be diagnosed through delayed skin tests such as the Mantoux test for tuberculosis.

Treatment

Management involves avoiding the causative antigen and using corticosteroids or immunosuppressants.

Tags

#Type IV hypersensitivity#cell-mediated immunity#delayed-type hypersensitivity#T-cell activation#immunology

0 people loved it

Recommended Reads

Explore related articles that might interest you

Microbiological Aspects of Vaccine-Preventable Diseases
11
11%

Microbiological Aspects of Vaccine-Preventable Diseases

Read more →
11
Mechanisms of Hypersensitivity Reactions
1
11%

Mechanisms of Hypersensitivity Reactions

Read more →
1
Antigens and Vaccine Development
12
11%

Antigens and Vaccine Development

Read more →
12
Human Leukocyte Antigen (HLA) System and Mechanisms of Transplant Rejection
45
11%

Human Leukocyte Antigen (HLA) System and Mechanisms of Transplant Rejection

Read more →
45
Principles and Mechanisms of Immunity
42
11%

Principles and Mechanisms of Immunity

Read more →
42
Microbiological Aspects of Vaccine-Preventable Diseases
7
11%

Microbiological Aspects of Vaccine-Preventable Diseases

Read more →
7
Epidemiology, microbiology, immunology, and clinical progression of viral hepatitis
30
11%

Epidemiology, microbiology, immunology, and clinical progression of viral hepatitis

Read more →
30
© 2025 MedGloss. All rights reserved.
Loading ad...